Zusammenfassung
Der aktuelle Stand des Wissens über die Kombinationsbehandlung von EKT mit Psychopharmaka in Akut- und Erhaltungsphase, und als Augmentationsstrategie wird zusammengefasst. In der Literatur finden sich relativ wenige schwere Nebenwirkungen unter dieser Kombinationsbehandlung, die meist bei hohen Medikamentendosen oder älteren und multimorbiden Patienten beobachtet wurden. Insbesondere für die Kombination von EKT mit Antidepressiva, Lithium oder Antipsychotika gibt es positive Argumente, die das Behandlungsergebnis und die Rückfallprophylaxe deutlich verbessern. Bei den Begleittherapien spielt besonders die Psychotherapie eine große Rolle und senkt das Rezidivrisiko nach einer EKT-Behandlung. Störungsspezifische Psychotherapie ist dringend zu empfehlen und sollte bereits in der Indexserie der EKT beginnen und in der Erhaltungsphase fortgesetzt werden. Eine Kombination von EKT mit anderen biologischen Verfahren und experimentellen Stimulationsverfahren kann zur Zeit nicht empfohlen werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Axmacher N, Elger CE, Fell J (2008) Ripples in the medial temporal lobe are relevant for human memory consolidation. Brain 131: 1806–1817
Baghai T, Marcuse A, Brosch M et al (2006) The influence of concomittant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 7(2): 82–90
Bernardo M, Navarro V, Salva J et al (2000) Seizure activity and safety in combined treatment with venlafaxine and ECT: A Pilot Study. J ECT 16(1): 38–42
Boggs JG (1997) Seizures in medically complex patients. Epilepsia 38(Suppl.4): 55–59
Boylan LS, Haskett RF, Roger F et al (2000) Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT 16(1): 3–8
Bragin A, Penttonen M, Buzsaki B (1997) Termination of epileptic after discharge in the hippocampus. J Neurosci 17: 2567–2579
Burke MJ, Husain MM (2006) Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT 22(3): 218–222
Chanpattana W, Kramer BA (2003) Acute and maintenance ECT with flupenthixol in refractory schizophrenia: Sustained improvements in psychopathology, quality of life and social outcomes. Schizophr Res 63: 189–193
Conca A, Koppi S, Magometschnigg M (2002) Einfluß der unilateralen Elektrokonvulsionstherapie auf die intra-kortikale Plastizität. Eine Voruntersuchung. J Neurol Neurochirur Psychiatr 2: 30–33
Conca A, Prapotnik M, Di Pauli J et al (2005) Psychotherapie und Elektrokonvulsionstherapie. Widerspruch oder Ergänzung. Nervenheilkunde 24: 729–735
Davidson J (1989) Seizures and Bupropion: a review. J Clin Psychiatry 50: 256–261
Dersch R, Zwernemann S, Voderholzer U (2011) Partial status epileptikus after elektrokonvulsive therapy and medical treatment with bupropion. Pharmacopsychiatry 44(7): 344–346
Diamond DM, Campbell A, Park CR et al (2004) Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. Eur Neuropsychopharmacol 14 Suppl 5: S 491–495
Dirmaier J, Steinmann M, Krattenmacher T et al (2012) Nonpharmacological treatment of depressive disorders: a review of evidence-based treatment options. Rev Recent Clin Trials (Epub ahead of print)
Dolenc TJ, Rasmussen KG (2005) The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. J ECT 21 (3): 165–170
Dolenc TJ, Habl S, Barnes RD et al (2004) Electroconvulsive therapy in patients taking monoamine oxidase inhibitors. J ECT 20(4): 258–261
Ducharme S, Flaherty AW, Seiner SJ et al (2011) Temporary interruption of deep brain stimulation for Parkinson’s disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy. J Neuropsychiatry Clin Neurosci 23(2): 194–197
Fakhri O, Fadhli AA, el Rawi RM (1980) Effect of electroconvulsive therapy on diabetes mellitus. Lancet 2(8198): 75–77
Farah A (1997) Mirtazapin and ECT combination therapy. Convuls Ther 13(2): 116–117
Farah A, Beale M, Kellner CH (1995) Risperidone and ECT combination therapy: A case series. Convuls Ther 11(4): 280–282
Eraslan D, Genc Y, Odabasioglu G et al (2011) Safety of electroconvulsive therapy-duloxetine combination. J ECT 27(3)
Fischer R, Kasper S, Pjrek E et al (2012) On the application of light therapy in German-speaking countries. Eur Arch Psychiatry Clin Neurosci 7 (Epub ahead of print)
Folkerts H (1997) Elektrokrampftherapie. Ein praktischer Leitfaden. Enke, Stuttgart
Gilabert E, Rojo E, Vallejo J (2004) Augmentation of electroconvulsive therapy seizures with sleep deprivation. J ECT 20(4): 242–247
Gonzalez-Pinto A, Gutierrez M, Gonzalez N et al (2002) Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression. J Neuropsychiatry Clin Neurosci 14: 206–209
Grundmann U, Oest M (2007) Anästhesiologische Aspekte bei Elektrokrampftherapie. Anaestesist 56: 202–211
Gupta S, Austin R, Devanand DP (1998) Lithium and maintenance elektroconvulsive therapy. J ECT 14(4): 241–244
Gutierrez-Esteinou R, Pope HG Jr (1989) Does fluoxetin prolong electrically induced seizures? Convuls Ther 5: 344–348
Hirose S, Ashby CR, Mills MJ (2001) Effectiveness of ECT combined with risperidon against aggression in schizophrenia. J ECT 17(1): 22–26
Horne RL, Ferguson JM, Pope HG Jr et al (1988) Treatment of bulimia with bupropion: a mulzicenter controlled trial. J Clin Psychiatry 49(7): 262–266
Imlah NW, Ryan E, Harrington JA (1965) The influence of antidepressant drugs on the response to electroconvulsive therapy and subsequent relapse rates. Neuropsychopharmacology 4: 438–442
Jha A, Stein G (1996) Decreased efficacy of combined benzodiazepines and unilateral ECT in treatment of depression. Acta Psychiatr Scand 94(2): 101–104
Jha A, Stein G, Fenwick P (1996) Negative interaction between lithium and electroconvulsive therapy – a case-control study. Br J Psychiatry 168(2): 241–243
Klapheke MM (1993) Combining ECT and antipsychotic agents: Benefits and risks. Convuls Ther 9(4): 241–255
Knapp M, Romeo R, Mogg A et al (2008) Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial. J Affect Disord 109(3): 273–285
Kranaster L, Janke C, Hausner L et al (2011) Venlafaxin associated postictal asystole during electrocunvulsive therapy. Pharmacopsychiatry (Epub ahead of print)
Krystal AD, Watts BV, Weiner RD et al (1998) The use of flumazanil in the anxious and benzodiazepine-dependent ECT patient. J ECT 14(1): 5–14
Kumar S, Goswami U, Behera D et al (2003) ECT and clozapine combination producing delirium: A case report. Indian J Psychiatry 45(III):193–193
Kupschik M, Spivak B, Mester R et al (2000) Combined electroconvulsive-clozapine therapy. Clin Neuropharmacology 23(1): 14–16
Lauritzen L, Odgaard K, Clemmesen L et al (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–251
Li TC, Shiah IS, Sun CJ et al (2011) Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: A case series and review of the literature. J ECT 27(2): 165–167
Lippmann SB, Tao CA (1993) Electroconvulsive therapy and lithium: Safe and effective treatment. Convuls Ther 9: 54–57
Lopez-Gonzales P, Chiclana C, Gonzales R (2009) Combined use of ECT with aripiprazole. World J Biolog Psychiatry 10(4): 942–943
Masdrakis VG, Oulis P, Zervas IM et al (2008) The safety of the electroconvulsive therapie-aripiprazol combination: four case reports. J ECT 24(3): 236–238
Masdrakis VG, Florakis A, Tzanoulinos G et al (2010) Safety of the electroconvulsive therapie-ziprasidone combination. J ECT 26(2): 139–142
Masdrakis VG, Tzanoulinos G, Markatou M et al (2011) Cardiac safety of the electroconvulsive therapy-paliperidone combination: a preliminary study. Gen Hosp Psychiatry 33: 83e9–10
McCall WV, Zvara D, Brooker R, Arias L (1997) Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT. Convuls Ther 13(3): 175–180
McClintock SM, Brandon AR, Husain MM et al (2011) A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression. J ECT 27(3): 236–243
Mukherjee S (1993) Combined ECT and lithium therapy. Convuls Ther 9(4): 274–284
Muller D (1961) 1. Nardil (phenelzine) as a potentiator of elektroconvulsive therapy (ECT). A survey of outpatient ECT. J Ment Sci 107: 994–996
Navarro V, Gasto C, Torres X et al (2008) Continuation/maintanance treatment with nortriptylin versus combined nortriptyline and ECT in late-life psychotic depression: A two-year randomized study. Am J Geriatr Psychiatry 16: 6
Nelson J, Benjamin L (1989) Efficacy and safety of combined ECT and tricyclic antidepressant drugs in the treatment of depressed geriatric patients. Convuls Ther 5: 321–329
Netzel JP, Mueller PS, Rummans TA et al (2002) Safety, efficacy and effekts on glycemic control of elektroconvulsive therapy in insulin-requiring type 2 diabetic patients. J ECT 18(1): 16–21
Normand PS, Jenike MA (1984) Lowered insulin requirements after ECT. Psychosomatics 25: 418–419
Nutt DJ, Gleiter CH, Linnoila M (1988) Repeated electroconvulsive shock normalizes blood glucose levels in genetically obese mice (C57BL/6 J ob/ob) but not in genetically diabetic mice (C57BL/KsJ db/db). Brain Res 448: 377–380
Peck AW, Stern WC, Watkinson C (1983) Incidence of seizures during treatment with tricyclic antidepressant drug and bupropion. J Clin Psychiatry 44(5Pt2): 197–201
Penland HR, Ostroff RB (2006) Combined use of lamotrigine and electroconvulsive therapy in bipolar depression: a case series. J ECT 22(2):142–147
Pettinati HM, Stephens SM, Willis KM et al (1990) Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psychiatry 147: 1029–1035
Porcelli S, Balzarro B, Serretti A (2012) Clozapine resistance: Augmentation strategies. Eur Neuropsychopharmacol 22(3): 165–182
Rasmussen KG (2011) Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. J ECT 27(1): 51–54
Rasmussen KG, Ryan DA, Mueller PS (2006) Blood glucose before and after ECT treatments in Type 2 diabetic patients. J ECT 22(2): 124–126
Ravanic DB, Pantovic MM, Milovanovic DR et al (2009) Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia. Psychiatria Danubina 21(2): 179–186
Rubner R, Koppi S, Conca A (2009) Frequency of and rationales for the combined use of electroconvulsive therapy in Austria and the literature. World J Biolog Psychiatry 10(4 Pt 3): 836–845
Rudorfer MV, Linnoila M, Potter WZ (1987) Combined lithium and electroconvulsive therapy: pharmacokinetic and pharmacodynamic interactions. Convuls Ther 3(1): 40–45
Rumi DO, Gattaz WF, Rigonatti SP et al (2005) Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 57(2): 162–166
Sachs G, Katschnig H (2010) Kombinierte Pharmako- und Psychotherapie. In: Riederer PF, Laux G Grundlagen der Neuropsychopharmakologie. Springer, Wien, S 575–588
Sackeim HA, Haskett RF, Mulsant BH et al (2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. JAMA 285(10): 1299–1307
Sackeim HA, Dillingham EM, Prudic J et al (2009) Effect of concomittant pharmacotherapy on electroconvulsive therapy outcomes. Arch Gen Psychiatry 66(7): 729–737
Saddichha S, Soy A, Vibha P (2009) Possible manic switch induced by combination of bupropion and electroconvulsive therapy in recurrent unipolar depression: a case series. BMJ Case Rep
Sartorius A, Wolf J, Henn FA (2005) Lithium and ECT-concurrent use still demands attention: three case reports. World J Biol Psychiatry 6(2): 121–124
Sienaert P, Peuskens J (2007) Anticonvulsants during electroconvulsive therapy: Review and recommendations. J ECT 23(3): 120–123
Sienaert P, Roelens Y, Dermunter H et al (2011) Concurrent use of lamotrigine and electroconvulsive therapy. J ECT 27(2): 148–152
Skuban T, Flohrer J, Klosterkötter J et al (2011) Psychiatric side effects of deep brain stimulation in Parkinson’s disease. Fortschr Neurol Psychiatr 79(12): 703–710
Squire L, Alvarez P (1995) Retrograde amnesia and consolidation: a neurobiological perspective. Curr Opin Neurobiol 5: 169–177
Squire L, Schimamura A, Graf P (1985) Independence of recognition memory and priming effects: a neuropsychological analysis. J Exp Psychol 11: 37–44
Stewart JT (1999) Lithium and maintenance ECT. J ECT 16(3): 300–301
Strömgren LS, Dahl J, Fjeldborg N et al (1980) Factors of influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta Psychiatr Scand 62(2): 158–165
Sutherland RJ, Sparks FT, Lehmann H (2010) Hippocampus and retrograde amnesia in the rat model: a modest proposal for the situation of systems consolidation. Neuropsychologia 48 (8): 2357–2369
Thirthalli J, Harish T, Gangadhar BN (2011) A prospective comparative study of interaction between lithium and modified electroconvulsive therapy. World J Biol Psychiatry 12(2): 149–155
Thomas A, Goldney R, Phillips P (1983) Depression electroconvulsive therapy and diabetes mellitus. Aust NZJ Psychiatry 2: 775–777
Volpe FM, Tavares AR (2012) Lithium plus ECT for mania in 90 cases: safety issues. J Neuropsychiatry Clin Neurosci 24(4): E33
Waarde JA van, Muller ME, Verwey B et al (2009) Exceptionally high initial seizure threshold in a catatonic patient treated with electroconvulsive therapy. J ECT 25(2): 121–124
Warnell RL, Elahi N (2007) Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis. J ECT 23(2): 114–119
Winocur G, Mascovitch M (2011) Memory transformation and systems consolidation. J Int Neuropsychol Soc 17 (5): 766–780
Wissenschaftlicher Beirat der Bundesärztekammer (2003) Stellungnahme zur Elektrokrampftherapie (EKT) als psychiatrische Behandlungsmaßnahme.
Yildiz A, Mantar A, Simsek S et al (2010) Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial. J ECT 26(2): 104–110
Zyss T, Krawczyk A, Zieba A et al (2010) Computer modelling of electroconvulsive treatment and transcranial magnetic stimulation – an explanation of poor efficacy of the magnetic method. Psychiatr Pol 44(6): 835–851
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schulz-Du Bois, A., Conca, A. (2013). EKT: Komedikation und begleitende Therapien. In: Grözinger, M., Conca, A., Nickl-Jockschat, T., Di Pauli, J. (eds) Elektrokonvulsionstherapie kompakt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25629-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-25629-5_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25628-8
Online ISBN: 978-3-642-25629-5
eBook Packages: Medicine (German Language)